Global Capsule Endoscopy Market to Grow at a CAGR of 8.7% During 2024-2032, Aided by the Growing Prevalence of Gastrointestinal Disorders Across the Globe

Global Capsule Endoscopy Market Overview

Capsule endoscopy is a non-invasive diagnostic procedure, wherein, a patient swallows a tiny camera the size of a pill that records images of the digestive tract as it passes through. It is used in the detection and surveillance of gastrointestinal disorders, including tumors, bleeding, and inflammation. An estimated 443.5 million new cases of digestive diseases were reported in 2019 which was a 74% increase from 1990 has been reported globally. Capsule endoscopes have seen significant improvements in data transmission, imaging technologies, and battery life, thereby, offering enhanced patient comfort and diagnostic accuracy.

Key Findings

• An increase in the incidence of gastrointestinal disorders like Crohn's disease, colorectal cancer, and ulcers is driving the market scope. This rise underscores the increasing global demand for better diagnostic and therapeutic approaches as each year these illnesses cause roughly 2.56 million deaths.
• The United States is likely to experience notable growth in the forecast period. The rising aging population, technological advancements in imaging technology and the increasing demand for minimally invasive diagnostic methods play a crucial role in boosting the market value.
• In May 2023, Chongqing Jinshan Science and Technology (CJST) introduced a significant advancement with the introduction of the fourth-generation capsule robot. With the integration of 5G, it has the ability to perform remote diagnoses. This fully automated system enables contactless, real-time medical assessments. In addition, the technology's improved automation and AI-assisted capabilities have been praised for revolutionizing gastrointestinal diagnostics.

Global Capsule Endoscopy Industry Growth Drivers

The advancements in technologies like improved battery life, imaging techniques and data transmission in capsule endoscopes have improved patient comfort and diagnostic accuracy, driving market expansion. In October 2023, Olympus Corporation introduced “EVIS X1”, its innovative endoscopy system in the United States. The system is intended to improve the identification and management of gastrointestinal disorders. Advanced imaging technologies such as texture and color enhancement imaging (TXI) to highlight anatomical details, brightness adjustment imaging (BAI-MAC) for the best possible image contrast, and red dichromatic imaging (RDI) for better visualization of deep blood vessels are all included in this system. These advancements are meant to help medical professionals identify and manage diseases like Crohn's disease, ulcers, and gastrointestinal bleeding.

Segment Analysis

Market Segmentation Based on Component is Anticipated to Witness Substantial Growth

Based on components, the market segmentation includes capsule endoscopes, recorders, and workstations. The patient wears recorders, which are external devices are used to record images sent wirelessly from the swallowed capsule. These recorders hold the data so that medical professionals can analyze it later and diagnose gastrointestinal disorders like Crohn's disease or small intestine problems.

Crohn’s Disease is Expected to Lead the Market Share

Based on disease, the segmentation constitutes obscure GI tract bleeding, Crohn’s disease, small intestine tumor, and others. The small intestine is difficult to access with traditional endoscopy, as a result, capsule endoscopy is used to detect and track Crohn's disease. This enables medical professionals to diagnose Crohn's disease in regions where it might not have otherwise been possible due to inflammation, ulcers, or other symptoms.

Competitive Landscape

• In May 2024, Medtronic introduced the PillCam Genius SB capsule endoscopy kit for both in-clinic and at-home procedures. This next-generation solution improves the patient experience by substituting outdated equipment with a simplified adhesive patch, greatly increasing comfort and accessibility was developed and approved. During an eight-hour procedure, the PillCam Genius SB can take up to 50,000 images, providing superior diagnostic capabilities for small bowel conditions such as Crohn's disease and subtle gastrointestinal bleeding.
• In March 2023, a non-binding memorandum of understanding (MOU) between NexOptic Technology Corp., and IntroMedic was established. This collaboration had a goal of developing capsule endoscopy technology and improving the imaging capabilities of IntroMedic's MiroCam® capsule endoscope, which already has excellent features like a 12-hour operating time and a 170-degree field of view. Patented technologies like Augmented Live-body Image Color-Spectrum Enhancement (ALICE) and Human Body Communication (HBC) power these innovations. The performance of these capsule endoscopes is anticipated to be further enhanced by NexOptic's AI-driven imaging solutions, such as ALIISTM (All Light Intelligent Imaging Solutions), which may allow both businesses to introduce improved products under a licensing arrangement.
• Other players involved in the market are Massachusetts Inst Technology, Broad Inst Inc., Given Imaging Ltd, Olympus Corp, Merck Sharp & Dohme, Progenity Inc., and Siemens AG, among others.

Regional Analysis

North America to Lead the Industry Share Based on Region 

Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America and Europe, rising collaborations and investments by key market players and advances in imaging technologies, is estimated to hold a high market value. Healthcare professionals are adopting capsule endoscopy to manage patients more proactively owning to the growing awareness of the advantages of early diagnosis for gastrointestinal conditions.

Key Offerings of the Report:

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for capsule endoscopy technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with capsule endoscopy.

Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for capsule endoscopy and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for capsule endoscopy and their relative value in the IP are covered in the final report. 

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790